🔎 Trials Near Me

Akèy › Fibrilasyon atriyal › Tennessee

Etid klinik pou Fibrilasyon atriyal nan Tennessee

12 etid pou Fibrilasyon atriyal ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Tennessee Center for Clinical Trials, Tullahoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • East Coast Institute for Research, Jefferson City, Jefferson City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07175428

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  • Jackson-Madison County General Hospital, Jackson
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT04088071

The Fourth Left Atrial Appendage Occlusion Study

  • The University of Tennessee, Memphis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05963698

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  • Tennessee Center for Clinical Trials, Tullahoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07430956

Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation

  • Erlanger Medical Center, Chattanooga
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05723926

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

  • Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07298473

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  • Anthos Investigational site 9954, Chattanooga
  • Anthos Investigative Site 9941, Jefferson City
  • Anthos Investigative Site 1056, Memphis
Ap rekriteFaz 3
Laj 65 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05712200

BoxX-NoAF Clinical Trial

  • Ascension Saint Thomas, Nashville
Ap rekriteVolontè an sante akeyi
Laj 65 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT06989775

Tracking Results of Ablations to Combat AF Registry Generation 2

  • Jackson Madison County General Hospital, Jackson
  • Centennial Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05111015

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • Fort Sanders Regional Medical Center, Knoxville
  • Methodist University Hospital, Memphis
  • Semmes Murphey Main Campus, Memphis
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT03907046

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

  • Vanderbilt University Medical Center, Nashville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06575881

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.